Phibro Animal Health Corporation
PAHC
$41.88
-$1.35-3.12%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 280.32% | 2,190.43% | 148.42% | 150.00% | 187.02% |
| Total Depreciation and Amortization | 42.49% | 41.53% | 37.19% | 29.90% | 1.50% |
| Total Amortization of Deferred Charges | 55.86% | 17.51% | 120.00% | 93.85% | 41.15% |
| Total Other Non-Cash Items | 151.28% | 298.54% | -82.76% | 221.48% | -147.37% |
| Change in Net Operating Assets | -1,813.02% | -168.22% | 182.07% | -191.20% | -36.57% |
| Cash from Operations | -26.30% | -25.17% | 278.28% | -90.25% | -22.08% |
| Capital Expenditure | -44.07% | -0.54% | 20.40% | 28.62% | -28.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -2,493.18% | -8,643.99% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -208.34% | -80.84% | -187.38% | 460.95% | 184.47% |
| Cash from Investing | -617.20% | 22.80% | -1,715.13% | -947.72% | 80.91% |
| Total Debt Issued | -84.83% | -53.29% | 30.65% | 1,045.24% | 1,011.76% |
| Total Debt Repaid | 88.85% | 45.37% | -101.61% | -294.92% | -1,247.78% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.08% | -0.06% | -0.10% | 0.02% | 0.00% |
| Other Financing Activities | -- | 95.00% | -258.12% | -11.85% | -496.72% |
| Cash from Financing | 155.95% | -534.58% | -763.84% | 1,979.09% | -2,352.85% |
| Foreign Exchange rate Adjustments | -85.32% | 269.18% | 537.96% | -69.47% | 369.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 125.19% | -62.31% | -138.95% | 249.63% | -1,102.99% |